CD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell Transplantation
Clinical trial NCT03564977 · UNKNOWN
Trial details
- NCT number
- NCT03564977
- Sponsor
- Qingdao Central Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-15
- Primary completion
- 2020-06-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.